US Bancorp’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-5,570
Closed -$151K 3776
2015
Q4
$151K Sell
5,570
-6,792
-55% -$175K ﹤0.01% 1835
2015
Q3
$270K Sell
12,362
-27,129
-69% -$692K ﹤0.01% 1587
2015
Q2
$1.13M Buy
39,491
+24,552
+164% +$715K ﹤0.01% 960
2015
Q1
$408K Buy
14,939
+14,853
+17,271% +$409K ﹤0.01% 1448
2014
Q4
$2K Sell
86
-909
-91% -$26.6K ﹤0.01% 3444
2014
Q3
$30K Sell
995
-1,310
-57% -$40.6K ﹤0.01% 2712
2014
Q2
$73K Sell
2,305
-85
-4% -$2.7K ﹤0.01% 2310
2014
Q1
$78K Sell
2,390
-106
-4% -$3.71K ﹤0.01% 2266
2013
Q4
$90K Buy
2,496
+256
+11% +$9.95K ﹤0.01% 2163
2013
Q3
$87K Buy
2,240
+1,230
+122% +$49.6K ﹤0.01% 2094
2013
Q2
$38K Buy
+1,010
New +$39.9K ﹤0.01% 2424

Other funds holding MR

US Bancorp's MR Position: Q1 2016 in Review

US Bancorp sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 5,570 shares — an estimated $151K sold.

US Bancorp first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $1.13M in Q2 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • US Bancorp reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • US Bancorp sold 5,570 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $151K.
  • US Bancorp first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • US Bancorp's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $1.13M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on US Bancorp's 13F filing for Q1 2016, filed 13 May 2016.